We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 49

Pfizer v. Novopharm

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 24 2009

The Federal Court granted prohibition in respect of a patent claiming the use of sildenafil for the treatment of erectile dysfunction by oral administration

Celgene v. Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 24 2009

Celgene is the current owner of several patents relating to thalidomide

Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug

Sanofi-Aventis v. Novopharm; preliminary questions regarding costs assessment

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Sanofi had brought a proceeding against Novopharm and joined Schering as the respondentpatentee pursuant to the NOC Regulations

Sanofi-Aventis v. Canada; PMPRB decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Sanofi was seeking judicial review of an interlocutory decision of the Board, which was made during the course of dealings that had lasted a number of years

Apotex & Novopharm v. Wellcome; interlocutory motion to amend pleadings

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

The Trial Division upheld the decision of the Prothonotary to allow GSK to amend its pleadings revising the quantum of damages sought in the proceeding

Eli Lilly v. Novopharm; merits of an infringement proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

After a trial on the merits, the Court found that the patent at issue was invalid as it is not a valid selection patent

Lundbeck v. Cobalt, Genpharm and Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court granted prohibition in respect of each of the proceedings against each defendant

Bristol-Myers Squibb v. Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court refused to grant prohibition on the basis that Apotex's allegation in respect of invalidity for obviousness was justified

Pfizer v. Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 7 2009

The Court upheld the decision of the Prothonotary refusing further production of ANDS documents